BIBI , N., and M. MALIK. “COMPARISON OF 550MG/DAY VERSES 1100 MG/DAY RIFAXIMIN IN SECONDARY PREVENTION OF BOTH COVERT AND OVERT HEPATIC ENCEPHALOPATHY”. Pakistan Journal of Intensive Care Medicine, vol. 5, no. 01, May 2025, p. 71, doi:10.54112/pjicm.v5i01.71.